Baseline mapping of Lassa fever virology, epidemiology and vaccine research and development-Reference-Cited by-同舟云学术

Baseline mapping of Lassa fever virology, epidemiology and vaccine research and development

Published:2018-03-20 Issue:1 Volume:3 Page:
ISSN:2059-0105
Container-title:npj Vaccines
language:en
Short-container-title:npj Vaccines

Author:

Hallam Hoai J.,Hallam Steven,Rodriguez Sergio E.,Barrett Alan D. T.,Beasley David W. C.,Chua Arlene^ORCID,Ksiazek Thomas G.,Milligan Gregg N.,Sathiyamoorthy Vaseeharan,Reece Lisa M.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Infectious Diseases,Pharmacology,Immunology

Link

http://www.nature.com/articles/s41541-018-0049-5.pdf

Reference147 articles.

1. Bausch, D. G. et al. Lassa fever in guinea: I. Epidemiology of human disease and clinical observations. Vector-Borne Zoonotic Dis. 1, 269–281 (2001).

2. Fichet-Calvet, E. & Rogers, D. J. Risk maps of Lassa fever in West Africa. PLoS. Negl. Trop. Dis. 3, e388 (2009).

3. Manning, J. T., Forrester, N. & Paessler, S. Lassa virus isolates from Mali and the Ivory Coast represent an emerging fifth lineage. Front. Microbiol. 6, 1037 (2015).

4. McCormick, J. B. et al. A case-control study of the clinical diagnosis and course of Lassa fever. J. Infect. Dis. 155, 445–455 (1987).

5. Andersen, K. G. et al. Clinical sequencing uncovers origins and evolution of Lassa virus. Cell 162, 738–750 (2015).

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Strategies of rational and structure-driven vaccine design for Arenaviruses;Infection, Genetics and Evolution;2024-09

2. Lassa Fever: Critical Review and Prospects for Control;Tropical Medicine and Infectious Disease;2024-08-14

3. Inactivated rabies-based Lassa fever virus vaccine candidate LASSARAB protects nonhuman primates from lethal disease;npj Vaccines;2024-08-09

4. Potent immunogenicity and protective efficacy of a multi-pathogen vaccination targeting Ebola, Sudan, Marburg and Lassa viruse;PLOS Pathogens;2024-06-26

5. A validate and standardized pseudotyped microneutralization assay as a safe and powerful tool to measure LASSA neutralising antibodies for vaccine development and comparison;F1000Research;2024-05-24